awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q51006519-50E2134F-D448-43CB-8A95-5C864CB1DC33
Q51006519-50E2134F-D448-43CB-8A95-5C864CB1DC33
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51006519-50E2134F-D448-43CB-8A95-5C864CB1DC33
Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK Inhibition.
P2860
Q51006519-50E2134F-D448-43CB-8A95-5C864CB1DC33
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51006519-50E2134F-D448-43CB-8A95-5C864CB1DC33
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1a0fcbfd4513bbbc41443248fba5f1836b77f3ae
P2860
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.